Key takeaways
- • **$199/mo advertised entry** for compounded semaglutide — no longer the cheapest we list.
- • **FDA warning letter 717989, 20 February 2026** — misbranding; no close-out published.
- • **Compounded only** — same FDA non-approval as Henry/Eden, but direct FDA action.
- • **Cash-pay only** — no insurance integration.
- • **Proceed with caution** per FDA action.
Pricing breakdown
| Item | Cost |
|---|---|
| Compounded semaglutide, advertised entry | $199/mo |
| Compounded semaglutide maintenance | $199-299/mo |
| Compounded tirzepatide | $199-399/mo |
| Insurance acceptance | None |
Prices as published 2026-06-05. Verify directly with provider before deciding.
What SkinnyRx does well
Publishes an advertised entry price ($199/mo) rather than quoting only after intake
Async-first fast intake
Tirzepatide compounded option available
Direct cash-pay simplicity
No telehealth fee separate
Provider network all 50 states
Where SkinnyRx falls short
FDA WARNING LETTER March 2026 — HIGHEST enforcement risk
Future supply continuity uncertain
No insurance integration
Limited long-term review data
Maintenance dose pricing approaches Henry/Eden parity
Brand pressure from FDA action may affect operations
Who SkinnyRx is best for
Best fit: Extremely cost-conscious patients comfortable with elevated FDA enforcement + supply continuity risk.
Poor fit: Risk-averse patients. Anyone who wants supply continuity. Anyone uncomfortable proceeding while an FDA misbranding letter is open and uncorrected on the public record.
SkinnyRx vs. other GLP-1 providers — compare
SponsoredSee how SkinnyRx stacks up against other telehealth GLP-1 providers, ranked by our editorial score. Visit a partner to check current pricing and eligibility — we compare and link, we never sell medication.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you — it never affects our rankings. How we make money
- Sesame Care· from $208/moTop ratedTelehealth · online visit
- SkinnyRx· from $199/moCompounded not offered in AL, LA, MS — check before startingTelehealth · online visitCompounded · not FDA-approved
- Enhance MD· price shown after their intakeNo lab work to startRestricted in AL, AR, GA, HI, LA, MS, MO, ND, SC, TN, WV — check before startingTelehealth · online visitCompounded · not FDA-approved
- HealthRX· from $165/moLowest starting priceon the 12-month plan, $1,188 billed upfrontTelehealth · online visitCompounded · not FDA-approved
FAQ
Should I use SkinnyRx after the FDA warning letter?
That is your decision and your clinician’s, not ours — but we will not route you there. The 20 February 2026 letter is open, with no close-out published, and it concerns how the product was described to buyers rather than a proven safety defect. If you want a compounded route, be aware there is no name in this category we can point you to as clean on this measure: Eden received its own misbranding letter on 8 June 2026, and we do not point readers to Henry Meds or Mochi Health for separate reasons set out on those pages. The route without an open letter is an FDA-approved brand product, which now starts at $149/month for the oral options.
What does the FDA warning letter mean?
It is a formal, public notice that the FDA believes a company is violating the Federal Food, Drug, and Cosmetic Act, and it demands a written response within 15 working days. It is not a recall, a criminal charge, or a court finding, and many letters are eventually closed out. SkinnyRx was one of about 30 telehealth companies to receive one on 20 February 2026, all under the same subject line: false and misleading claims, misbranded. The specific findings against SkinnyRx concerned who was named as the compounder on the label and language implying equivalence to Mounjaro and Zepbound.
Will I lose my prescription if SkinnyRx stops operating?
It is a real risk to plan for, though nothing in the 20 February letter orders SkinnyRx to stop. A warning letter that is not resolved can escalate to seizure or injunction, and past FDA enforcement against compounders has produced shutdowns on short notice. Keep a record of your current dose and the date of your last fill so another prescriber can pick up your titration without restarting it.
What does SkinnyRx actually cost?
Their product page advertises compounded injectable semaglutide from $199/mo (checked 7 August 2026). We previously cited a $69 entry price; that figure no longer appears anywhere on skinnyrx.com and should be treated as withdrawn. Maintenance doses run higher than the entry price, so budget for the titrated dose rather than the headline.
Bottom line
Extremely cost-conscious patients comfortable with elevated FDA enforcement + supply continuity risk. See full provider ranking for full context across our full provider ranking.
Ready to try SkinnyRx?
Get started with SkinnyRxSponsored — we may earn a commission if you sign up, at no extra cost to you. It never affects our editorial ranking.
Sources
Editorial only — not medical advice. Pricing accurate as of 2026-06-05; verify with SkinnyRx before deciding.